Carteolol HCl EP Impurity F

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	APB04060
Synonyms	5-(2-hydroxy-3-methoxypropoxy)-3,4-dihydroquinolin-2(1H)-one
Molecular Weight	251.28
Molecular Formula	C13H17NO4

What is the molecular weight of Carteolol HCl EP Impurity F?

The molecular weight of Carteolol HCl EP Impurity F is 251.28.

What is the molecular formula of Carteolol HCl EP Impurity F?

The molecular formula of Carteolol HCl EP Impurity F is C13H17NO4.

Are there any synonyms for Carteolol HCl EP Impurity F?

Yes, a synonym for Carteolol HCl EP Impurity F is 5-(2-hydroxy-3-methoxypropoxy)-3,4-dihydroquinolin-2(1H)-one.

What is the chemical structure of Carteolol HCl EP Impurity F?

The chemical structure of Carteolol HCl EP Impurity F is C13H17NO4.

How is Carteolol HCl EP Impurity F usually obtained?

Carteolol HCl EP Impurity F is usually obtained as a raw material or impurity during the synthesis of Carteolol HCl.

What is the significance of Carteolol HCl EP Impurity F in pharmaceutical manufacturing?

Carteolol HCl EP Impurity F is important in pharmaceutical manufacturing as it needs to be controlled and monitored to ensure the quality and safety of the final drug product.

Can Carteolol HCl EP Impurity F impact the efficacy of the final drug product?

Yes, Carteolol HCl EP Impurity F can impact the efficacy of the final drug product if present in significant quantities.

How is Carteolol HCl EP Impurity F detected and quantified in pharmaceuticals?

Carteolol HCl EP Impurity F is typically detected and quantified using analytical techniques such as HPLC (High-Performance Liquid Chromatography).

What are the potential risks associated with the presence of Carteolol HCl EP Impurity F in pharmaceuticals?

The presence of Carteolol HCl EP Impurity F in pharmaceuticals can pose risks such as reduced efficacy, potential toxicity, and regulatory non-compliance.

How can pharmaceutical manufacturers ensure the control of Carteolol HCl EP Impurity F in their production processes?

Pharmaceutical manufacturers can ensure the control of Carteolol HCl EP Impurity F by implementing robust quality control measures, conducting regular testing and monitoring, and following regulatory guidelines for impurity levels.

* Products or Services Interested: Carteolol HCl EP Impurity F ()
* Your question
* Name
* Email
Verification Code

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry